Literature DB >> 26690518

Combined effect between two functional polymorphisms of SLC6A12 gene is associated with temporal lobe epilepsy.

Jingyun Li1, Hua Lin, Fenghe Niu, Xilin Zhu, Ning Shen, Xin Wang, Liping Li, Aihua Liu, Xiaopan Wu, Wei Sun, Yuping Wang, Ying Liu.   

Abstract

Temporal lobe epilepsy (TLE) is the most common epilepsy subtype with complex genetic structure. A recent study in four populations (Ireland, UK, Australia and Finland) reported an allelic association between betaine/GABA transporter-1(BGT-1 or SLC6A12) and mesial temporal lobe epilepsy with hippocampal sclerosis. To demonstrate the association between SLC6A12 gene polymorphisms and TLE, TaqMan method was used to genotype five single-nucleotide polymorphisms of SLC6A12 gene in 358 TLE patients and 596 nonepileptic control subjects of Chinese Han origin. Real-time PCR was used to detect the effects of variations on gene expression associated with TLE. Though, the single-marker analysis did not demonstrate allelic association with TLE, rs542736-rs557881 interaction showed significant association. The SLC6A12 expression levels in peripheral blood mononuclear cells were significantly higher in TLE patients than in control subjects and were correlated to rs542736 G-rs557881 A haplotypes. Our preliminary results suggested combined effect of two common polymorphisms on SLC6A12 gene may be associated with TLE, but the precise mechanism needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26690518     DOI: 10.1007/s12041-015-0567-0

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  26 in total

1.  A light and electron microscopic study of betaine/GABA transporter distribution in the monkey cerebral neocortex and hippocampus.

Authors:  Xiao-Ming Zhu; Wei-Yi Ong
Journal:  J Neurocytol       Date:  2004-03

Review 2.  Astrocyte dysfunction in neurological disorders: a molecular perspective.

Authors:  Gerald Seifert; Karl Schilling; Christian Steinhäuser
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

3.  Cerebrospinal fluid and plasma gamma-aminobutyric acid in Alzheimer's disease.

Authors:  M F Weiner; S G Speciale; R C Risser; G L Kramer; F Petty
Journal:  Biol Psychiatry       Date:  1996-11-01       Impact factor: 13.382

4.  Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy.

Authors:  E Aronica; K Fluiter; A Iyer; E Zurolo; J Vreijling; E A van Vliet; J C Baayen; J A Gorter
Journal:  Eur J Neurosci       Date:  2010-02-26       Impact factor: 3.386

Review 5.  Neurotransmitter transporters: three distinct gene families.

Authors:  S G Amara; J L Arriza
Journal:  Curr Opin Neurobiol       Date:  1993-06       Impact factor: 6.627

Review 6.  Benign mesial temporal lobe epilepsy.

Authors:  Angelo Labate; Antonio Gambardella; Eva Andermann; Umberto Aguglia; Fernando Cendes; Samuel F Berkovic; Frederick Andermann
Journal:  Nat Rev Neurol       Date:  2011-01-25       Impact factor: 42.937

7.  Changes in GABA transporters in the rat hippocampus after kainate-induced neuronal injury: decrease in GAT-1 and GAT-3 but upregulation of betaine/GABA transporter BGT-1.

Authors:  Xiao-Ming Zhu; Wei-Yi Ong
Journal:  J Neurosci Res       Date:  2004-08-01       Impact factor: 4.164

8.  Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study.

Authors:  Gianpiero L Cavalleri; Michael E Weale; Kevin V Shianna; Rinki Singh; John M Lynch; Bronwyn Grinton; Cassandra Szoeke; Kevin Murphy; Peter Kinirons; Deirdre O'Rourke; Dongliang Ge; Chantal Depondt; Kristl G Claeys; Massimo Pandolfo; Curtis Gumbs; Nicole Walley; James McNamara; John C Mulley; Kristen N Linney; Leslie J Sheffield; Rodney A Radtke; Sarah K Tate; Stephanie L Chissoe; Rachel A Gibson; David Hosford; Alice Stanton; Tracey D Graves; Michael G Hanna; Kai Eriksson; Anne-Mari Kantanen; Reetta Kalviainen; Terence J O'Brien; Josemir W Sander; John S Duncan; Ingrid E Scheffer; Samuel F Berkovic; Nicholas W Wood; Colin P Doherty; Norman Delanty; Sanjay M Sisodiya; David B Goldstein
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

Review 9.  MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.

Authors:  Prasun J Mishra; Pravin J Mishra; Debabrata Banerjee; Joseph R Bertino
Journal:  Cell Cycle       Date:  2008-01-28       Impact factor: 4.534

10.  Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected].

Authors:  Q R Liu; B López-Corcuera; S Mandiyan; H Nelson; N Nelson
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

View more
  1 in total

1.  Involvement of upregulation of miR-210 in a rat epilepsy model.

Authors:  Licheng Chen; Hao Zheng; Shimeng Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-13       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.